These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 26990051)
1. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis. Husain MI; Strawbridge R; Stokes PR; Young AH J Psychopharmacol; 2017 Sep; 31(9):1137-1148. PubMed ID: 28858537 [TBL] [Abstract][Full Text] [Related]
3. Targeting the immune system in the treatment of bipolar disorder. Rosenblat JD Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials. Rosenblat JD; McIntyre RS J Affect Disord; 2018 Feb; 227():219-225. PubMed ID: 29102836 [TBL] [Abstract][Full Text] [Related]
5. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression. Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489 [TBL] [Abstract][Full Text] [Related]
6. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. Köhler O; Benros ME; Nordentoft M; Farkouh ME; Iyengar RL; Mors O; Krogh J JAMA Psychiatry; 2014 Dec; 71(12):1381-91. PubMed ID: 25322082 [TBL] [Abstract][Full Text] [Related]
7. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders. Ayorech Z; Tracy DK; Baumeister D; Giaroli G J Affect Disord; 2015 Mar; 174():467-78. PubMed ID: 25553408 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis. Liang L; Chen J; Xiao L; Wang Q; Wang G Transl Psychiatry; 2022 Jan; 12(1):4. PubMed ID: 35013098 [TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Zheng W; Zhang QE; Cai DB; Yang XH; Qiu Y; Ungvari GS; Ng CH; Berk M; Ning YP; Xiang YT Acta Psychiatr Scand; 2018 May; 137(5):391-400. PubMed ID: 29457216 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Sarris J; Mischoulon D; Schweitzer I J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis. Xu H; Du Y; Wang Q; Chen L; Huang J; Liu Y; Zhou C; Du B Asian J Psychiatr; 2023 Feb; 80():103394. PubMed ID: 36525766 [TBL] [Abstract][Full Text] [Related]
14. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. Bai S; Guo W; Feng Y; Deng H; Li G; Nie H; Guo G; Yu H; Ma Y; Wang J; Chen S; Jing J; Yang J; Tang Y; Tang Z J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):21-32. PubMed ID: 31658959 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials. Allison DJ; Sharma B; Timmons BW Physiol Behav; 2019 Aug; 207():104-112. PubMed ID: 31078670 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review. Fond G; Hamdani N; Kapczinski F; Boukouaci W; Drancourt N; Dargel A; Oliveira J; Le Guen E; Marlinge E; Tamouza R; Leboyer M Acta Psychiatr Scand; 2014 Mar; 129(3):163-79. PubMed ID: 24215721 [TBL] [Abstract][Full Text] [Related]
19. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Sidor MM; Macqueen GM J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686 [TBL] [Abstract][Full Text] [Related]
20. Adjunctive minocycline for major mental disorders: A systematic review. Zheng W; Zhu XM; Zhang QE; Cheng G; Cai DB; He J; Ng CH; Ungvari GS; Peng XJ; Ning YP; Xiang YT J Psychopharmacol; 2019 Oct; 33(10):1215-1226. PubMed ID: 31294649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]